The FDA no longer requires a safety warning on hormone-replacement therapies, at a time when more attention is being paid to perimenopause and menopause.

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the ...

Hormone replacement therapy can be a way for women to prevent the inflammation that leads to disease. "There's some bone ...

Menopause hormone therapy has evolved through decades of research, offering relief from symptoms like hot flashes, sleep ...

There is no strong evidence that replenishing hormones after menopause is linked to dementia, according to a sweeping ...

Birth control isn’t just for younger people looking to delay pregnancy. Women in perimenopause also need to think about how ...

Hormone replacement therapy (HRT) to treat menopause symptoms does not increase dementia risk, according to a new study.

Impulsive, anxious, overheated, scatter-brained, depressed and in pain are just some of the terms that many women use to describe themselves when they reach perimenopause, or the years that precede ...

Researchers in Canada reported in Neurology that transdermal estradiol improved episodic memory scores in postmenopausal ...

The FDA said it will remove most "black box" safety warnings from hormone drugs used to treat menopause symptoms. Newer research shows these medications are safer than previously believed, especially ...

Constance Zimmer was on birth control “for way too long.” “My general practitioner had told me I should get off my birth ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: ADHD and menopause symptoms can overlap, and one ...